NCT00284128 - AVE7688 in Patients With Mild to Moderate Blood Pressure | Biotech Hunter

Enrollment

1,940

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Hypertension

Interventions

DRUG

AVE7688

oral administration (capsules)

DRUG

Losartan-potassium

oral administration (capsules)

Trial Locations (21)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, São Paulo

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Athens

Sanofi-Aventis Administrative Office, Causeway Bay

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Kuala Lumpur

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Porto Salvo

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Singapore

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Seoul

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Taipei

Sanofi-Aventis Administrative Office, Istanbul